Because of these reasons, developing an efficient computer-aided quantification tool that provides accurate and reliable anatomical tumor volumes, its extent, as well as metabolic activity estimations for HER2-positive tumors is highly desirable. The gene discussed is ERBB2; the disease is neoplasm.